FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140638239> ?p ?o ?g. }

• W2140638239 endingPage "1184" @default.
• W2140638239 startingPage "1173" @default.
• W2140638239 abstract "Purpose To evaluate the safety and effectiveness of the retrievable Option inferior vena cava (IVC) filter in patients at risk for pulmonary embolism (PE). Materials and Methods This was a prospective, multicenter, single-arm clinical trial. Subjects (N = 100) underwent implantation of the IVC filter and were followed for 180 days; subjects whose filters were later removed were followed for 30 days thereafter. The primary objective was to determine whether the one-sided lower limit of the 95% CI for the observed clinical success rate was at least 80%. Clinical success was defined as technical success (deployment of the filter such that it was judged suitable for mechanical protection from PE) without subsequent PE, significant filter migration or embolization, symptomatic caval thrombosis, or other complications. Results Technical success was achieved in 100% of subjects. There were eight cases of recurrent PE, two cases of filter migration (23 mm), and three cases of symptomatic caval occlusion/thrombosis (one in a subject who also experienced filter migration). No filter embolization or fracture occurred. Clinical success was achieved in 88% of subjects; the one-sided lower limit of the 95% CI was 81%. Retrieval was successful at a mean of 67.1 days after implantation (range, 1–175 d) for 36 of 39 subjects (92.3%). All deaths (n = 17) and deep vein thromboses (n = 18) were judged to have resulted from preexisting or intercurrent illnesses or interventions and unrelated to the filter device; all deaths were judged to be unrelated to PE. Conclusions Placement and retrieval of the Option IVC filter were performed safely and with high rates of clinical success. To evaluate the safety and effectiveness of the retrievable Option inferior vena cava (IVC) filter in patients at risk for pulmonary embolism (PE). This was a prospective, multicenter, single-arm clinical trial. Subjects (N = 100) underwent implantation of the IVC filter and were followed for 180 days; subjects whose filters were later removed were followed for 30 days thereafter. The primary objective was to determine whether the one-sided lower limit of the 95% CI for the observed clinical success rate was at least 80%. Clinical success was defined as technical success (deployment of the filter such that it was judged suitable for mechanical protection from PE) without subsequent PE, significant filter migration or embolization, symptomatic caval thrombosis, or other complications. Technical success was achieved in 100% of subjects. There were eight cases of recurrent PE, two cases of filter migration (23 mm), and three cases of symptomatic caval occlusion/thrombosis (one in a subject who also experienced filter migration). No filter embolization or fracture occurred. Clinical success was achieved in 88% of subjects; the one-sided lower limit of the 95% CI was 81%. Retrieval was successful at a mean of 67.1 days after implantation (range, 1–175 d) for 36 of 39 subjects (92.3%). All deaths (n = 17) and deep vein thromboses (n = 18) were judged to have resulted from preexisting or intercurrent illnesses or interventions and unrelated to the filter device; all deaths were judged to be unrelated to PE. Placement and retrieval of the Option IVC filter were performed safely and with high rates of clinical success." @default.
• W2140638239 created "2016-06-24" @default.
• W2140638239 creator A5007044838 @default.
• W2140638239 creator A5007818750 @default.
• W2140638239 creator A5010238438 @default.
• W2140638239 creator A5039147064 @default.
• W2140638239 creator A5048058458 @default.
• W2140638239 creator A5055755821 @default.
• W2140638239 creator A5063245590 @default.
• W2140638239 creator A5073446532 @default.
• W2140638239 creator A5078104013 @default.
• W2140638239 creator A5086737942 @default.
• W2140638239 creator A5087174632 @default.
• W2140638239 date "2010-08-01" @default.
• W2140638239 modified "2023-09-26" @default.
• W2140638239 title "The Safety and Effectiveness of the Retrievable Option Inferior Vena Cava Filter: A United States Prospective Multicenter Clinical Study" @default.
• W2140638239 cites W1986622513 @default.
• W2140638239 cites W1991340886 @default.
• W2140638239 cites W2015206271 @default.
• W2140638239 cites W2032761344 @default.
• W2140638239 cites W2039766346 @default.
• W2140638239 cites W2067143182 @default.
• W2140638239 cites W2082271946 @default.
• W2140638239 cites W2095329800 @default.
• W2140638239 cites W2109819743 @default.
• W2140638239 cites W2128062473 @default.
• W2140638239 cites W2132493430 @default.
• W2140638239 cites W2137591261 @default.
• W2140638239 cites W2156320702 @default.
• W2140638239 cites W2312814626 @default.
• W2140638239 cites W4255679514 @default.
• W2140638239 doi "https://doi.org/10.1016/j.jvir.2010.04.004" @default.
• W2140638239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20598570" @default.
• W2140638239 hasPublicationYear "2010" @default.
• W2140638239 type Work @default.
• W2140638239 sameAs 2140638239 @default.
• W2140638239 citedByCount "89" @default.
• W2140638239 countsByYear W21406382392012 @default.
• W2140638239 countsByYear W21406382392013 @default.
• W2140638239 countsByYear W21406382392014 @default.
• W2140638239 countsByYear W21406382392015 @default.
• W2140638239 countsByYear W21406382392016 @default.
• W2140638239 countsByYear W21406382392017 @default.
• W2140638239 countsByYear W21406382392018 @default.
• W2140638239 countsByYear W21406382392019 @default.
• W2140638239 countsByYear W21406382392020 @default.
• W2140638239 countsByYear W21406382392021 @default.
• W2140638239 countsByYear W21406382392022 @default.
• W2140638239 countsByYear W21406382392023 @default.
• W2140638239 crossrefType "journal-article" @default.
• W2140638239 hasAuthorship W2140638239A5007044838 @default.
• W2140638239 hasAuthorship W2140638239A5007818750 @default.
• W2140638239 hasAuthorship W2140638239A5010238438 @default.
• W2140638239 hasAuthorship W2140638239A5039147064 @default.
• W2140638239 hasAuthorship W2140638239A5048058458 @default.
• W2140638239 hasAuthorship W2140638239A5055755821 @default.
• W2140638239 hasAuthorship W2140638239A5063245590 @default.
• W2140638239 hasAuthorship W2140638239A5073446532 @default.
• W2140638239 hasAuthorship W2140638239A5078104013 @default.
• W2140638239 hasAuthorship W2140638239A5086737942 @default.
• W2140638239 hasAuthorship W2140638239A5087174632 @default.
• W2140638239 hasConcept C126838900 @default.
• W2140638239 hasConcept C141071460 @default.
• W2140638239 hasConcept C188816634 @default.
• W2140638239 hasConcept C2776035437 @default.
• W2140638239 hasConcept C2776265017 @default.
• W2140638239 hasConcept C2776268601 @default.
• W2140638239 hasConcept C2777185221 @default.
• W2140638239 hasConcept C2778959117 @default.
• W2140638239 hasConcept C2780011451 @default.
• W2140638239 hasConcept C2780828045 @default.
• W2140638239 hasConcept C2780868729 @default.
• W2140638239 hasConcept C2910216633 @default.
• W2140638239 hasConcept C71924100 @default.
• W2140638239 hasConceptScore W2140638239C126838900 @default.
• W2140638239 hasConceptScore W2140638239C141071460 @default.
• W2140638239 hasConceptScore W2140638239C188816634 @default.
• W2140638239 hasConceptScore W2140638239C2776035437 @default.
• W2140638239 hasConceptScore W2140638239C2776265017 @default.
• W2140638239 hasConceptScore W2140638239C2776268601 @default.
• W2140638239 hasConceptScore W2140638239C2777185221 @default.
• W2140638239 hasConceptScore W2140638239C2778959117 @default.
• W2140638239 hasConceptScore W2140638239C2780011451 @default.
• W2140638239 hasConceptScore W2140638239C2780828045 @default.
• W2140638239 hasConceptScore W2140638239C2780868729 @default.
• W2140638239 hasConceptScore W2140638239C2910216633 @default.
• W2140638239 hasConceptScore W2140638239C71924100 @default.
• W2140638239 hasIssue "8" @default.
• W2140638239 hasLocation W21406382391 @default.
• W2140638239 hasLocation W21406382392 @default.
• W2140638239 hasOpenAccess W2140638239 @default.
• W2140638239 hasPrimaryLocation W21406382391 @default.
• W2140638239 hasRelatedWork W2126095206 @default.
• W2140638239 hasRelatedWork W2352976444 @default.
• W2140638239 hasRelatedWork W2383158841 @default.
• W2140638239 hasRelatedWork W2413348391 @default.
• W2140638239 hasRelatedWork W3031791182 @default.
• W2140638239 hasRelatedWork W3032065286 @default.

• next